SEB SA (0MGS)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 56.28 |
|---|---|
| 52-week range | 38.81 – 61.95 |
| Return, 1 month / 3 months | +1.6% / +15.6% |
| Return, 1 year / 3 years | +22.7% / −28.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 51 |
| Volatility (1 year) | 35.9% |
| Worst drawdown (1 year) | -22.6% |
| Average daily value traded | 0.50M EUR |
| Dividend yield | 5.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SEB SA is a French maker of small domestic appliances and cookware for households. Its products include pots and pans, pressure cookers, fryers, kettles, coffee machines, vacuum cleaners and garment care appliances, sold under brands such as Tefal, Moulinex, Rowenta and Krups. The company serves consumers through retailers and online channels in many countries, and it is based in France.
The shares are listed on the London Exchange in UK under the code 0MGS, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SEB SA (0MGS) trades on the London Exchange in UK. It last closed at EUR 56.28 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 763 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.7% and over the last three months it rose 15.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.5% | ||
| From 52-week high | -7.5% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 15.6% | ||
| 6-month return | 21.5% | ||
| 12-month return, skipping the last month | 20.8% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.6% | ||
| Liquidity | 46 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.50M EUR | ||
| Zero-volume days | 5.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +3.5% |
|---|---|
| 1 month | +1.6% |
| 3 months | +15.6% |
| 6 months | +21.5% |
| 1 year | +22.7% |
| 3 years | −28.5% |
| 5 years | −45.3% |
Signals
| 50-day / 200-day average | 57.14 / 50.49 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 May 2026 | EUR 2.8000 |
| 3 Jun 2025 | EUR 2.8000 |
| 3 Jun 2024 | EUR 2.6200 |
| 31 May 2023 | EUR 2.4500 |
| 31 May 2022 | EUR 2.4500 |
| 25 May 2021 | EUR 2.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.